Among the four main BC subtypes (luminal A, luminal B, basal-like and human epidermal growth factor receptor 2 (HER2)-enriched [2–4]), luminal BC express hormonal receptors and are considered sensitive to endocrine therapy. Here, NR4A1 is linked to breast cancer.